We are live on ! Find out more
TECX

Tectonic Therapeutic

54 hedge funds and large institutions have $15.7M invested in Tectonic Therapeutic in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.29% less ownership

Funds ownership: 4.94%4.65% (-0.29%)

16% less funds holding

Funds holding: 6454 (-10)

34% less capital invested

Capital invested by funds: $23.8M → $15.7M (-$8.17M)

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

63% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 16

Holders
54
Holders Change
-10
Holders Change %
-15.63%
% of All Funds
0.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
10
Reduced
18
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$2.9M
GC
2
GMT Capital
Georgia
$2.25M
KPF
3
K2 Principal Fund
Ontario, Canada
$1.76M +$1.5M +135,270 +146%
BlackRock
4
BlackRock
New York
$1.29M +$2.35K +212 +0.1%
Renaissance Technologies
5
Renaissance Technologies
New York
$785K -$309K -27,805 -21%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$758K +$53.8K +4,850 +5%
Vanguard Group
7
Vanguard Group
Pennsylvania
$743K +$127K +11,402 +13%
ACM
8
Aisling Capital Management
New York
$646K
FCM
9
Farallon Capital Management
California
$475K
Millennium Management
10
Millennium Management
New York
$456K -$78.6K -7,082 -11%
Goldman Sachs
11
Goldman Sachs
New York
$454K +$517K +46,532 +376%
MB
12
MPM BioImpact
Massachusetts
$416K
Citadel Advisors
13
Citadel Advisors
Florida
$329K -$166K -14,941 -26%
Morgan Stanley
14
Morgan Stanley
New York
$329K -$21.6K -1,947 -4%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$252K -$163K -14,650 -31%
Two Sigma Investments
16
Two Sigma Investments
New York
$252K -$74.9K -6,751 -17%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$248K
NLVP
18
New Leaf Venture Partners
New York
$203K
SW
19
SVB Wealth
Massachusetts
$183K +$263K +23,697 New
GCP
20
GSA Capital Partners
United Kingdom
$114K -$141K -12,745 -46%
BCM
21
Bridgeway Capital Management
Texas
$100K +$19.4K +1,750 +16%
State Street
22
State Street
Massachusetts
$90K
E
23
Ergoteles
New York
$71K -$27.1K -2,441 -21%
PFMU
24
Privium Fund Management (UK)
United Kingdom
$70K +$101K +9,133 New
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$63K -$325K -29,267 -78%

TECX Hedge Fund Activity: Q3 2022 in Review

54 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q3 2022, worth a combined $15.7M — down 34% from $23.8M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of TECX and 6 opened new positions — a net loss of 10 holders — while 18 trimmed existing stakes and 10 added.

The largest buyer was K2 Principal Fund, adding an estimated $1.5M. The largest seller was JP Morgan Chase, cutting an estimated $1.9M.

  • 54 institutional investors held Tectonic Therapeutic (TECX) as of Q3 2022, down from 64 in Q2 2022.
  • Funds reported $15.7M of Tectonic Therapeutic stock for Q3 2022, down 34% quarter-over-quarter.
  • 6 funds opened new Tectonic Therapeutic positions in Q3 2022 and 16 closed out, a net change of -10 holders.
  • The largest Tectonic Therapeutic buyer in Q3 2022 was K2 Principal Fund, an estimated $1.5M added.
  • The largest Tectonic Therapeutic seller in Q3 2022 was JP Morgan Chase, an estimated $1.9M sold.

Based on aggregated 13F filings for Q3 2022.